Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

NEP and ECE inhibitors reported by Kali-Chemie

Nov. 15, 1996

Clinical trials update on nibentan, Russian antiarrhythmic drug

Nov. 15, 1996

Chugai discloses antiischemic agents

Nov. 15, 1996

FDA approves once-daily antihypertensive combination

Nov. 15, 1996

Biovail licenses once-daily diltiazem

Nov. 15, 1996

Endothelin antagonists claimed by E. Merck

Nov. 15, 1996

Fujisawa describes ACE and/or NEP inhibitors

Nov. 15, 1996

Dual ACE/NEP inhibitors from Fujisawa

Nov. 15, 1996

Potential antiischemic/antiarrhythmic agent reported

Nov. 8, 1996

Suntory's new sodium/calcium channel blockers

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...